Global Stem Cell Exosome Therapeutic Market

Report ID : 1133 | Published : 2021-07-27 | Pages: 140 | Format: PDF/EXCEL

The Global Market for Stem Cell Exosome Therapeutic was valued at US$ xx Mn in 2019 and it is expected to reach US$ xx million in 2030, recording a promising CAGR of 16% during the period of 2020-2030. Exosomes are gaining popularity rapidly as a method to access the therapeutic benefits of stem cells without the complications and difficulties of delivering the cells to patients. Exosomes are sold as diagnostic devices, therapeutic agents, cosmeceuticals, research tools, and much more. The increasing prevalence of autoimmune disease, chronic inflammation, lyme disease, and other chronic degenerative diseases is expected to boost the demand for stem cell exosome therapeutic. Additionally, the emerging research activities in exosome therapeutics are likely to accelerate the market growth in upcoming years. In the last few years, the technologies related to exosomes have been mainly developed and the demand for these technologies are very useful the fields of precision medicine, liquid biopsy, and regenerative medicine. Therefore, this is further projected to enhance the adoption of stem cell exosome therapeutic. Moreover, advancements in exosome isolation and purification techniques and rising healthcare infrastructure is likely to offer lucrative growth opportunities to the global stem cell exosome therapeutic in the next few years.

The Stem Cell Exosome Therapeutics Market is a segment based on source type, application, and geography. In terms of source type, the global market is segregated into MSC, dendritic cells, umbilical MSC, plasma, and others. In 2019, the MSC or mesenchymal stem cells segment accounted for a significant share of the global stem cell exosome therapeutics market. Mesenchymal stem cells (MSCs) are one of the most commonly employed cell types as a cell-based therapy for treating human diseases. Mesenchymal stem cells are multipotent, self-renewable, easily manageable, and customarily stretchy in vitro with exceptional genomic stability. It is widely used in the treatment of degenerative and inflammatory disease offspring cells encompassing the transgene after transplantation. Mesenchymal stem cells are used to repair injured organs such as the lung, heart, and kidney. Moreover, the dendritic cells segment is anticipated to grow at the highest CAGR during the forecast period. Based on the application, the market is segmented into precision medicine, regenerative medicine, and others. Regenerative medicine is the largest contributing category to the global stem cell exosome therapeutic market. Regenerative medicine seeks to enhance the regeneration of tissue and organs that are damaged, malfunctioning and incomplete. Stem cell therapies are promising therapeutics in this field in damaged organs such as the myocardium after heart infarction, spinal cord injury, stroke, damaged liver, and retina diseases. Mesenchymal stem cells represent a promising stem cell population for applications in regenerative medicine. Moreover, stem cell exosome therapeutic has potential applications in precision medicine.

Geographically, the global stem cell exosome therapeutic market has been segmented into North America, Asia Pacific, Latin America, Europe, and Middle East & Africa. North America dominates the global stem cell exosome therapeutic market due to the increasing number of autoimmune diseases. Additionally, the emerging research activities required for exosome therapeutics are also projected to boost market growth. Moreover, the U.S. dominated the regional market owing to the rising preventive expenditure for healthcare and the presence of leading manufacturers of stem cell exosome therapeutics. Europe is anticipated to be the second-largest market for stem cell exosome therapeutic due to the developed healthcare sectors. Furthermore, the Asia Pacific is expected to grow at the highest CAGR with the improved healthcare services, especially in the emerging economies of Asia Pacific. Some of the market players leading the global stem cell exosome therapeutic market include Direct Biologics, MDimune Inc., ExoCoBio, Exopharm Pty Ltd, Invitrx Inc., OmniSpirant Limited, RoosterBio Inc., Stemcell Medicine Ltd., VivaZome Therapeutics Pty Ltd, Evox Therapeutics, Kimera Labs, The Cell-Factory BVBA (Esperite), Capricor Therapeutics, Inc., Unicyte AG, Exogenus Therapeutics, Everkine Corporation, Creative Medical Technology Holdings, Anjarium Biosciences, ReNeuron, Stem Cell Medicine Ltd., and Codiak Biosciences Key players of stem cell exosome therapeutics are primarily focusing on product innovation, joint ventures, regional expansion, and investment in research and development. For instance, Stem Cells Group has recently announced expansion of its new stem cell offices in Cochabamba, Bolivia and Valencia, Spain.

Chapter 1. Methodology and Scope

1.1. Research Methodology

1.2. Research Scope & Assumptions

Chapter 2. Executive Summary

Chapter 3. Global Stem Cell Exosome Therapeutic Market Snapshot

Chapter 4. Global Stem Cell Exosome Therapeutic Market Variables, Trends & Scope

4.1. Market Segmentation & Scope

4.2. Market Dynamics - Drivers

4.3. Challenges/Restraints

4.4. Market Trends

4.5. Industry Analysis – Porter’s Five Forces Analysis

Chapter 5. Market Segmentation 1: Source Type Estimates & Trend Analysis

5.1. Source Type & Market Share, 2019 & 2028

5.2. Market Size (Value) & Forecasts and Trend Analyses, 2019 to 2028 for the following Source Type:

5.2.1. MSC

5.2.2. Dendritic Cells

5.2.3. Umbilical MSC

5.2.4. Plasma

5.2.5. Others

Chapter 6. Market Segmentation 1: Application Estimates & Trend Analysis

6.1. Application & Market Share, 2019 & 2028

6.2. Market Size (Value) & Forecasts and Trend Analyses, 2019 to 2028 for the following Application:

6.2.1. Precision Medicine

6.2.2. Regenerative Medicine

6.2.3. Others

Chapter 7. Stem Cell Exosome Therapeutic Market Segmentation 3: Regional Estimates & Trend Analysis

7.1. North America

7.1.1. North America Stem Cell Exosome Therapeutic Market revenue (US$ Million) estimates and forecasts by Source Type, 2019-2028

7.1.2. North America Stem Cell Exosome Therapeutic Market revenue (US$ Million) estimates and forecasts by Application, 2019-2028

7.1.3. North America Stem Cell Exosome Therapeutic Market revenue (US$ Million) estimates and forecasts by country, 2019-2028

7.1.3.1. U.S.

7.1.3.2. Canada

7.2. Europe

7.2.1. Europe Stem Cell Exosome Therapeutic Market revenue (US$ Million) estimates and forecasts by Source Type, 2019-2028

7.2.2. Europe Stem Cell Exosome Therapeutic Market revenue (US$ Million) estimates and forecasts by Application, 2019-2028

7.2.3. Europe Stem Cell Exosome Therapeutic Market revenue (US$ Million) by country, 2019-2028

7.2.3.1. Germany

7.2.3.2. Poland

7.2.3.3. France

7.2.3.4. Italy

7.2.3.5. Spain

7.2.3.6. UK

7.2.3.7. Rest of Europe

7.3. Asia Pacific

7.3.1. Asia Pacific Stem Cell Exosome Therapeutic Market revenue (US$ Million) estimates and forecasts by Source Type, 2019-2028

7.3.2. Asia Pacific Stem Cell Exosome Therapeutic Market revenue (US$ Million) estimates and forecasts by Application, 2019-2028

7.3.3. Asia Pacific Stem Cell Exosome Therapeutic Market revenue (US$ Million) by country, 2019-2028

7.3.3.1. China

7.3.3.2. India

7.3.3.3. Japan

7.3.3.4. Australia

7.3.3.5. Rest of Asia Pacific

7.4. Latin America

7.4.1. Latin America Stem Cell Exosome Therapeutic Market revenue (US$ Million) estimates and forecasts by Source Type, 2019-2028

7.4.2. Latin America Stem Cell Exosome Therapeutic Market revenue (US$ Million) estimates and forecasts by Application, 2019-2028

7.4.3. Latin America Stem Cell Exosome Therapeutic Market revenue (US$ Million) by country, (US$ Million) 2019-2028

7.4.3.1. Brazil

7.4.3.2. Rest of Latin America

7.5. MEA

7.5.1. MEA Stem Cell Exosome Therapeutic Market revenue (US$ Million) estimates and forecasts by Source Type, 2019-2028

7.5.2. MEA Stem Cell Exosome Therapeutic Market revenue (US$ Million) estimates and forecasts by Application, 2019-2028

7.5.3. MEA revenue Stem Cell Exosome Therapeutic Market revenue (US$ Million) by country, (US$ Million) 2019-2028

7.5.3.1. South Africa

7.5.3.2. Rest of MEA

Chapter 8. Competitive Landscape

8.1. Major Mergers and Acquisitions/Strategic Alliances

8.2. Company Profiles

8.2.1. Evox Therapeutics

8.2.1.1. Company Overview

8.2.1.2. Financials

8.2.1.3. Source portfolio

8.2.1.4. Business strategy & Recent developments

8.2.2. Capricor Therapeutics, Inc.

8.2.3. Unicyte AG

8.2.4. Exogenus Therapeutics

8.2.5. Everkine Corporation

8.2.6. Creative Medical Technology Holdings

8.2.7. Anjarium Biosciences

8.2.8. Kimera Labs

8.2.9. ReNeuron

8.2.10. Stem Cell Medicine Ltd.

8.2.11. Codiak Biosciences

8.2.12. Other Prominent Players

Global Stem Cell Exosome Therapeutic Market Segmentation

 

Global Stem Cell Exosome Therapeutic Market Outlook (Value (US$ Mn), 2019-2030 By Source Type

  • MSC
  • Dendritic Cells
  • Umbilical MSC
  • Plasma
  • Others

Global Stem Cell Exosome Therapeutic Market Outlook (Value (US$ Mn), 2019-2030 By Application

  • Precision Medicine
  • Regenerative Medicine
  • Others

Global Stem Cell Exosome Therapeutic Market Outlook (Value (US$ Mn), 2019-2030 By Region

Europe Stem Cell Exosome Therapeutic Market Outlook (Value (US$ Mn), 2019-2030 By Country

  • Germany
  • Poland
  • France
  • Italy
  • Spain
  • UK
  • Rest of Europe

North America Stem Cell Exosome Therapeutic Market Outlook (Value (US$ Mn), 2019-2030 By Country

  • U.S.
  • Canada

Asia Pacific Stem Cell Exosome Therapeutic Market Outlook (Value (US$ Mn), 2019-2030 By Country

  • China
  • India
  • Japan
  • Australia
  • Rest of Asia Pacific

Latin America Stem Cell Exosome Therapeutic Market Outlook (Value (US$ Mn), 2019-2030 By Country

  • Brazil
  • Rest of Latin America

Middle East & Africa Stem Cell Exosome Therapeutic Market Outlook (Value (US$ Mn), 2019-2030 By Country

  • South Africa
  • Rest of Middle East & Africa

 

InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.

Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.

Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.

Secondary research

The secondary research sources that are typically mentioned to include, but are not limited to:

  • Company websites, financial reports, annual reports, investor presentations, broker reports, and SEC filings.
  • External and internal proprietary databases, regulatory databases, and relevant patent analysis
  • Statistical databases, National government documents, and market reports
  • Press releases, news articles, and webcasts specific to the companies operating in the market

The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista

Primary Research:

Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies

The contributors who typically take part in such a course include, but are not limited to: 

  • Industry participants: CEOs, CBO, CMO, VPs, marketing/ type managers, corporate strategy managers, and national sales managers, technical personnel, purchasing managers, resellers, and distributors.
  • Outside experts: Valuation experts, Investment bankers, research analysts specializing in specific markets
  • Key opinion leaders (KOLs) specializing in unique areas corresponding to various industry verticals
  • End-users: Vary mainly depending upon the market

Data Modeling and Analysis:

In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.

The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.

To know more about the research methodology used for this study, kindly contact us/click here.

Need Complete Report ?
Our Clients